The
corporate results season continued in earnest last week.
Some 60 per cent of companies in the S&P 500 have
released earnings numbers so far and of these, two thirds
have beaten analyst expectations. However, much of the
improvement is due to stringent cost cutting measures
by companies rather then increasing sales. In the US,
the weaker dollar has also had a positive effect on the
overall earnings picture. Many companies were also fairly
subdued in their statements about the outlook for the
coming months. Consequently, the markets failed to gather
substantial momentum in response to earnings data during
the week.
It
was a quiet week for economic news. In the US, unemployment
claims released on Thursday were lower then expected.
Durable goods' orders came in higher than forecast. However,
the Conference Board in the US posted a negligible 0.1
percent gain in its index of leading economic indicators.
In Europe, German inflation data fell below 1% again in
July.
The deaths of Uday and Qusay Hussein in Iraq proved to
be of minor interest to investors and markets in most
countries traded sideways. However, oil prices fell some
5 per cent on the news as expectations for a pick up in
Iraqi oil supplies mounted.
The
Table below shows the movements in the main markets since
last week's comment.
|
Market
|
Index
|
%
Return 18.07.2003
to 25.07.2003 |
| |
|
Local
Currency |
Euro |
| US |
S&P
500 |
0.5 |
-1.4 |
| US |
NASDAQ |
1.3 |
-0.7 |
| Europe |
FT/S&P
Europe Ex. UK |
0.4 |
0.4 |
| Ireland |
ISEQ |
-2.6 |
-2.6 |
| UK |
FTSE
100 |
1.4 |
1.3 |
| Japan |
Topix |
1.3 |
-1.0 |
| Hong
Kong |
Hang
Seng |
-2.0 |
-3.9 |
| Australia |
S&P/ASX
200 |
0.5 |
1.0 |
| Bonds |
Merrill
Lynch € over 5 yrs |
0.5 |
0.5 |
Corporate
earnings reports dominated investment markets in the US
last week. Merck, the US pharmaceutical giant, missed
analyst forecasts and also lowered sales forecasts for
some of its blockbuster drugs. AOL Time Warner, the media
conglomerate released good earnings reports but these
were overshadowed by lower subscribed additions.
In Europe, there was encouraging results from the pharmaceutical
sector which helped to lift investor sentiment. Swiss
company Roche saw its stock price rise some 5 per cent
when its earnings matched expectations. Meanwhile, German
pharmaceutical and chemicals company, Merck kGaA, posted
a 35 percent rise in profits.
In Asia, the Hong Kong market fell as profit taking continued
in the H-share index, which lists Chinese rather than
Hong Kong based stocks. The index had risen to five years
highs in recent weeks. However, the rally on the index
seems to have run out of steam over the last number of
days.